Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.24 - $1.2 $9,936 - $49,680
-41,400 Reduced 47.92%
45,000 $11,000
Q1 2022

May 16, 2022

SELL
$0.94 - $2.38 $76,328 - $193,256
-81,200 Reduced 48.45%
86,400 $104,000
Q4 2021

Feb 14, 2022

SELL
$1.89 - $3.12 $170,289 - $281,112
-90,100 Reduced 34.96%
167,600 $434,000
Q3 2021

Nov 15, 2021

SELL
$2.34 - $3.77 $334,854 - $539,487
-143,100 Reduced 35.7%
257,700 $603,000
Q2 2021

Aug 16, 2021

SELL
$3.48 - $4.45 $1.17 Million - $1.49 Million
-335,200 Reduced 45.54%
400,800 $1.46 Million
Q1 2021

May 17, 2021

BUY
$3.57 - $6.2 $883,575 - $1.53 Million
247,500 Added 50.67%
736,000 $2.71 Million
Q4 2020

Feb 16, 2021

SELL
$4.4 - $7.32 $192,720 - $320,616
-43,800 Reduced 8.23%
488,500 $2.55 Million
Q3 2020

Nov 16, 2020

BUY
$4.38 - $8.35 $1.3 Million - $2.47 Million
295,700 Added 124.98%
532,300 $2.74 Million
Q2 2020

Aug 14, 2020

SELL
$3.64 - $9.26 $175,812 - $447,258
-48,300 Reduced 16.95%
236,600 $1.75 Million
Q1 2020

May 15, 2020

BUY
$2.54 - $9.38 $64,262 - $237,314
25,300 Added 9.75%
284,900 $1.13 Million
Q4 2019

Feb 14, 2020

BUY
$7.07 - $9.51 $463,085 - $622,905
65,500 Added 33.75%
259,600 $2.47 Million
Q3 2019

Nov 14, 2019

BUY
$7.77 - $11.26 $25,641 - $37,158
3,300 Added 1.73%
194,100 $1.51 Million
Q2 2019

Aug 14, 2019

BUY
$7.91 - $10.25 $204,078 - $264,450
25,800 Added 15.64%
190,800 $1.78 Million
Q1 2019

May 15, 2019

BUY
$6.0 - $11.07 $792,600 - $1.46 Million
132,100 Added 401.52%
165,000 $1.49 Million
Q4 2018

Feb 14, 2019

SELL
$5.81 - $7.89 $34,860 - $47,340
-6,000 Reduced 15.42%
32,900 $201,000
Q3 2018

Nov 14, 2018

BUY
$6.57 - $8.31 $181,989 - $230,187
27,700 Added 247.32%
38,900 $294,000
Q2 2018

Aug 14, 2018

BUY
$3.93 - $8.93 $44,016 - $100,016
11,200 New
11,200 $90,000

Others Institutions Holding QTNT

# of Institutions
1
Shares Held
1.71K
Call Options Held
0
Put Options Held
0

About Quotient Ltd


  • Ticker QTNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Description
  • Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological di...
More about QTNT
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.